Gut-Antibiotic Impact

Undesirable microorganisms can easily disrupt the function and balance of the gut microbiome. Whether from changes in medications, environment, diet, or other factors, friendly, resident gut bacteria often need support and a quality probiotic can help.

Clinical studies have demonstrated the restorative power of OMNi-BiOTiC® AB 10 with outcomes including a significant reduction in AAD, improvement in digestive health and comfort, as well as complete resolution of CDI.

Read This Next
“Insights into the Composition of a Co-Culture of 10 Probiotic Strains (OMNi BiOTiC® AAD10) and Effects of Its Postbiotic Culture Supernatant”
Year Published: 2022
Study Type: preclinical
Related Omni-Biotic Formulation: AB 10
(marketed as AAD 10 in EU)

In a preclinical study, the postbiotic supernatant of cultured Omni-Biotic AB 10 was analyzed by liquid chromatography mass spectroscopy (LC-MS) and gas chromatography mass spectroscopy (GC-MS). The characterized postbiotic supernatant had positive antibacterial and antifungal effects in vitro and promoted growth of distinct, health-promoting bacteria.
Read full study
"Effect of a Multispecies Probiotic on Intestinal and Skin Colonization by Multidrug Resistant Gram Negative Bacteria in Patients in a Long Term Care Facility"
Year Published: 2020
Study Type: pilot study
Related Omni-Biotic Formulation: AB 10

Elderly long term care facility patients colonized with multidrug resistance gram negative bacteria were treated with Omnio-Biotic AB 10 (AAD) for twelve weeks. Colonization was eliminated in 58% of patients at 8-20 weeks following intervention.
Read full study
"Probiotics Use for Antibiotic Associated Diarrhea: A Pragmatic Participatory Evalution in Nursing Homes"
Year Published: 2020
Study Type: participatory evaluation
Related Omni-Biotic Formulation: AB 10
Omni-Biotic AB 10 (AAD) was administered to residents receiving antibiotics at three nursing homes. Compared to a control group receiving antibiotics without probiotic supplementation, the AB 10 group demonstrated significantly fewer episodes of antibiotic associated diarrhea.
Read full study
"Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic"
Year Published: 2013
Study Type: retrospective review
Related Omni-Biotic Formulation: AB 10

This retrospective chart review of ten CDI patients for whom recurrence was expected found that all patients on adjunctive Omni-Biotic AB 10 (AAD) therapy showed complete clinical resolution.
Read full study
"Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis"
Year Published: 2013
Study Type: review article
Related Omni-Biotic Formulation: AB 10

This systematic review and meta-analysis evaluated the efficacy of co-administration of probiotics with antibiotics. Findings demonstrated that probiotics used concurrently with antibiotics reduce the risk of antibiotic associated diarrhea and C. difficile infection.
Read full study
"Use of a multi-species probiotic for the prevention of antibiotic associated diarrhea"
Year Published: 2010
Study Type: observational study
Related Omni-Biotic Formulation: AB 10

This observational study demonstrated the successful use of Omni-Biotic AB 10 (AAD) for primary prevention of antibiotic associated diarrhea in post surgical patients.
Read full study